Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Medtronic
Harvard Business School
Moodys
Johnson and Johnson
Mallinckrodt

Last Updated: November 15, 2019

DrugPatentWatch Database Preview

Litigation Details for Insys Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Insys Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-09-13
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Colm F. Connolly
Jury Demand None Referred To
Parties INSYS DEVELOPMENT COMPANY, INC.; INSYS THERAPEUTICS, INC.; TEVA PHARMACEUTICAL INDUSTRIES LTD.; TEVA PHARMACEUTICALS USA, INC.
Patents 10,016,403; 8,486,972; 8,486,973; 8,835,459; 8,835,460; 9,241,935; 9,289,387; 9,642,797; 9,642,844
Attorneys Chad J. Peterman; Christopher P. Galligan; David M. Fry; Deirdre M. Wells; Gerald J. Flattmann , Jr.; J.C. Rozendaal; Jack B. Blumenfeld; Jennifer Ying; Joseph T. Jaros; Josephine J. Kim; Karen Elizabeth Keller; Katie A. Boda; Lucas L. Kressel; Maja E. Sherman; Maryellen Noreika; Michael A. Stramiello; Nathan Roger Hoeschen; Naveen Modi; Paul A. Ainsworth; Paul J. Molino; Tara Mythri Raghavan; William A. Rakoczy
Firms Morris, Nichols, Arsht & Tunnell; Shaw Keller LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Insys Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Insys Therapeutics, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 1 United States Patent Nos. 8,486,972 (“the ’972 patent”); 8,486,973 (“the ’973 patent”); 8,835,459 (“…(“the ’459 patent”); 8,835,460 (“the ’460 patent”); 9,241,935 (“the ’935 patent”); 9,289,387 (“the ’387…’387 patent”); 9,642,797 (“the ’797 patent”); and 9,642,844 (“the ’844 patent”); (collectively, “the …the ’973 patent and two claims of the ’844 patent, but not the other claims in those patents. Further…the patents-in-suit”). (Exhibits A–H.) This action arises under the Patent Laws of the United States, 35 External link to document
0000-00-00 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,486,972 B2; 8,486,973 B2; 8,835,459…13 September 2017 1:17-cv-01303 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 64 Notice of Service Initial Invalidity Contentions Regarding U.S. Patent No. 10,016,403 filed by Teva Pharmaceuticals USA, Inc..…13 September 2017 1:17-cv-01303 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
McKesson
Moodys
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.